These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26609650)

  • 1. Metabolic syndrome in schizophrenia - who is more to blame: FGA polypharmacy or clozapine monotherapy?
    Softic R; Sutovic A; Avdibegovic E; Osmanović E; Bećirović E; Hajdukov MM
    Psychiatr Danub; 2015 Dec; 27(4):378-84. PubMed ID: 26609650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does antipsychotic polypharmacy increase the risk for metabolic syndrome?
    Correll CU; Frederickson AM; Kane JM; Manu P
    Schizophr Res; 2007 Jan; 89(1-3):91-100. PubMed ID: 17070017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardio-metabolic risk and its management in a cohort of clozapine-treated outpatients.
    Lappin JM; Wijaya M; Watkins A; Morell R; Teasdale S; Lederman O; Rosenbaum S; Dick S; Ward P; Curtis J
    Schizophr Res; 2018 Sep; 199():367-373. PubMed ID: 29486959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.
    Krane-Gartiser K; Breum L; Glümrr C; Linneberg A; Madsen M; Køster A; Jepsen PW; Fink-Jensen A
    Nord J Psychiatry; 2011 Oct; 65(5):345-52. PubMed ID: 21428861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of the metabolic syndrome among patients receiving clozapine.
    Lamberti JS; Olson D; Crilly JF; Olivares T; Williams GC; Tu X; Tang W; Wiener K; Dvorin S; Dietz MB
    Am J Psychiatry; 2006 Jul; 163(7):1273-6. PubMed ID: 16816234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic Polypharmacy and Its Relation to Metabolic Syndrome in Patients With Schizophrenia: An Egyptian Study.
    Aly El-Gabry DM; Abdel Aziz K; Okasha T; Azzam H; Okasha A
    J Clin Psychopharmacol; 2018 Feb; 38(1):27-33. PubMed ID: 29210867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia.
    Said MA; Hatim A; Habil MH; Zafidah W; Haslina MY; Badiah Y; Ramli MA; Ananjit S; Sapini Y; Shah M; Mahmud B; Bulgiba A; Hairi NN
    Prev Med; 2013; 57 Suppl():S50-3. PubMed ID: 23337566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations.
    Velligan DI; Carroll C; Lage MJ; Fairman K
    Psychiatr Serv; 2015 Feb; 66(2):127-33. PubMed ID: 25321616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia.
    Bai YM; Chen JY; Yang WS; Chi YC; Liou YJ; Lin CC; Wang YC; Lin CY; Su TP; Chou P
    J Clin Psychiatry; 2007 Dec; 68(12):1834-9. PubMed ID: 18162013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome.
    Jeon SW; Kim YK
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29057817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype.
    Zhang Y; Chen M; Chen J; Wu Z; Yu S; Fang Y; Zhang C
    Psychopharmacology (Berl); 2014 May; 231(10):2211-8. PubMed ID: 24448899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the risk of antipsychotic polypharmacy discontinuation dependent on the agents used?
    Constantine RJ; Andel R; McPherson M; Tandon R
    Psychiatry Res; 2018 May; 263():238-244. PubMed ID: 29195836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using an Integrated Care Pathway for Late-Life Schizophrenia Improves Monitoring of Adverse Effects of Antipsychotics and Reduces Antipsychotic Polypharmacy.
    Abdool PS; Supasitthumrong T; Patel K; Mulsant BH; Rajji TK
    Am J Geriatr Psychiatry; 2019 Jan; 27(1):84-90. PubMed ID: 30396766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine use and sedentary lifestyle as determinants of metabolic syndrome in outpatients with schizophrenia.
    Eskelinen S; Sailas E; Joutsenniemi K; Holi M; Suvisaari J
    Nord J Psychiatry; 2015 Jul; 69(5):339-45. PubMed ID: 25981178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews.
    Ijaz S; Bolea B; Davies S; Savović J; Richards A; Sullivan S; Moran P
    BMC Psychiatry; 2018 Sep; 18(1):275. PubMed ID: 30176844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.
    Smith RC; Segman RH; Golcer-Dubner T; Pavlov V; Lerer B
    Pharmacogenomics J; 2008 Jun; 8(3):228-36. PubMed ID: 17726453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvements in body composition, anthropometric measurements and lipid profile following discontinuation of clozapine.
    Wysokiński A; Sobów T
    Nord J Psychiatry; 2016; 70(2):156-60. PubMed ID: 26140393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and its relation to antipsychotic polypharmacy in schizophrenia, schizoaffective and bipolar disorders.
    Abdel Aziz K; Mohd Ahmed H; Stip E; Aly El-Gabry D
    Int Clin Psychopharmacol; 2024 Jul; 39(4):257-266. PubMed ID: 38381917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: a randomized controlled trial.
    Constantine RJ; Andel R; McPherson M; Tandon R
    Schizophr Res; 2015 Aug; 166(1-3):194-200. PubMed ID: 26141142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic monitoring and management among clozapine users.
    Tso G; Kumar P; Jayasooriya T; Kisely S; Siskind D
    Australas Psychiatry; 2017 Feb; 25(1):48-52. PubMed ID: 27590080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.